NI Technology Updates Outlooks for PMC-Sierra, Cavium, EZchip, Marvell and NetLogic

PRINCETON, N.J., Sept. 22 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), an online investment newsletter focused on semiconductor and technology stocks, has published updated outlooks for PMC-Sierra (Nasdaq: PMCS), Cavium (Nasdaq: CAVM), EZchip (Nasdaq: EZCH), Marvell (Nasdaq: MRVL) and NetLogic (Nasdaq: NETL).

Editor Paul McWilliams has displayed uncanny accuracy in identifying winners and losers during this challenging and historic period for the markets. After calling the rally that started in March 2009 to the day and providing Next Inning readers with buy recommendations that in some cases returned in excess of 400%, he advised readers on May 3, 2010 that the markets were heading for a correction.  By the end of the day, the correction started.

In his June 7th Strategy Review, McWilliams advised readers we would see stocks rally in July, but that the rally would be followed by another selloff in August. As we know now, both events materialized as predicted.  On August 30th, Next Inning published McWilliams' Fall Strategy Review that outlines what he expects from the markets during the coming three months and naming five stocks he thinks will hit new highs before the close of the year.  Investors are invited to read McWilliams' market insights with no obligation during a 21-day risk-free trial.

Trial subscribers will receive the Next Inning Fall Strategy Review and highly acclaimed State of Tech reports that offer in-depth, sector-by-sector coverage of over 65 leading tech companies and specific guidance on which stocks he thinks investors should own and which should be avoided.  These reports, as well as McWilliams' regular commentary and detailed earnings previews, are available for free to trial subscribers.

In addition, subscribers will have access to McWilliams' daily commentary and actionable alerts.  To take advantage of this offer and receive these reports for free, please visit the following link:

https://www.nextinning.com/subscribe/index.php?refer=prn1094

McWilliams covers these topics and more in his recent reports:

-- With PMC-Sierra lowering its revenue guidance last night, does McWilliams think the company has a lingering problem or is this likely a short-term blip? What is his current fair value range for the stock following the lowered guidance?

-- The price of Cavium has nearly tripled since McWilliams advised Next Inning readers to buy the stock as a good strategic investment.  Does he still view the stock as a core strategic holding or does he see better avenues to cover the sector today?  Does he think Cavium will report an upside for Q3 or that its revenue might disappoint due to lighter demand at Cavium's largest customer, Cisco?  How does McWilliams view Cavium's performance outside Cisco and what does he see as drivers for the company in 2011?

-- McWilliams named EZchip as his top pick for 2010 in two stock-picking contests reserved for newsletter writers last December.  As it stands today, due to the fact the price of EZchip has more than doubled this year and is one of the top-performing tech stock for the year, he leads in both contests by a large margin.  What has driven the price of EZchip this year and does McWilliams see the trends continuing in 2011?  Were analysts right in their claims that Juniper's move away from EZchip will stifle the company's growth in 2011?  What does the design success EZchip has enjoyed with its new NP-4 Network Processor mean for EZchip going forward?  What exciting new markets will EZchip open with its new NPA processor in 2011?  Does McWilliams think EZchip is destined to set yet another new high later in 2010?

-- While down from where it started the year, the price of Marvell is still more than 170% above where it traded when McWilliams advised Next Inning readers it was a good speculative investment.  Why has the price of Marvell declined so much since the company set its year-to-date high in April?  Was the market right to sell off Marvell or has it created a good buying opportunity for investors who missed their first chance when McWilliams originally pointed to the stock.  What is going on at Marvell under the covers that Wall Street has yet to factor into the price?  What is the one thing unique in the Marvell business model that McWilliams thinks will spur significant growth in 2011?  If this works out as McWilliams has outlined, might Marvell be the next semiconductor stock to double?

-- Like Marvell, the price of NetLogic has also fallen notably from its year-to-date high, but it is still trading more than 160% above where it was when McWilliams encouraged Next Inning readers to buy it as a good strategic investment.  What has caused the weakness in NetLogic since its price peaked earlier in the year?  Does McWilliams think the decline was merited or that it has created a buying opportunity for investors who have waited patiently?  What does McWilliams see as an estimated fair price range for NetLogic?

Founded in September 2002, Next Inning's model portfolio has returned 269% since its inception versus 25% for the S&P 500.  

About Next Inning:

Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks.  Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+ year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926.  Interested parties may visit adviserinfo.sec.gov for additional information.  Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515

SOURCE Indie Research Advisors, LLC